Biotech Tours Specialist Thai Medical Vacation Announces Breakthrough Treatment For Heart Disease
ThaiMedicalVacation.com, an independent Biotech Tours Facilitator specializing in securing Advanced Medical Solutions in Asia announced a breakthrough partnership to provide Stem Cell Therapy for Heart Disease and Congestive Heart Failure
Thai Medical Vacation an independent medical tours facilitator specializing in securing advanced medical & cosmetic surgery Thailand and Asia, today introduced an unique alliance to supply stem cell therapy for heart disease The joint venture helps solidify the biotech tours providers position as the premiere provider of state-of-the-art medical tours to Asia.
Coronary Disease is a global concern and Congestive heart failure is recognized as one of the quickest growing cardiovascular diseases in the world, affecting in excess of 140 million people on the planet each year, with new heart disease cases totaling well over 1,500,000 on a yearly basis.
• In countries like the US, congestive heart failure or CHF is regarded as the principal reason behind hospitalization and eventual death in people over 65 years old
• in 2009, around 730,000 citizens in the US had a heart attack and more than 60% will have another heart attack.
• Global statistics have are much more alarming with some estimations reaching as high as one coronary related death every Thirty seconds.
• The AMA or American Heart Association has recently estimated the financial costs of heart failures and heart disease treatments in the United States at well over $30 billion per year
“Heart disease continues its reign to be the number one killer of humans with cancer, the number 2 killer, not very far behind. The tragedy of these deadly diseases is that they can all be cured today if we had sufficient funding and focus from authorities around the world” said Lala P.Wong, Senior VP of Operations at Thai Medical Vacation Co. Ltd.
“The goal of stem cell therapy for heart disease is simple, our therapy objectives and protocols call for an increase in the exercise capacity,increase in End-diastolic and End-systolic and ejection fraction. The survival rate is also much better in the treated group who underwent stem cell therapy for heart disease"
The autologous stem cells are extracted from the individuals bone marrow,peripheral blood, or adipose tissue depending on the yield and health of the selected source of stem cells. The treatment focuses primarily on regeneration of tissue and creation of new blood vessels via angiogenesis. Angiogenesis has also shown promising results in the stem cell treatment for autism & the recently announced stem cell diabetes treatment.
The Stem Cell Therapy for Heart Disease procedure is relatively safe when compared to open heart surgery or bypass and is performed out on an out-patient basis, thereby limiting the overall risk especially when compared to the alternative solutions available today.
The stem cell therapy for heart disease requires approximately 10-14 days stay in Thailand or China.
- Contact Information
- Lala P. Wong
- Senior VP of Operations
- Thai Medical Vacation Co.Ltd
- (1) 347-450-8424
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.